RS

Rasika Swapnesh Dhakare

Active Director Director DIN 09176172
DIN 09176172 First appointment May 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rasika Swapnesh Dhakare

Data last updated:

Rasika Swapnesh Dhakare is a Director at Dakshata Healthcare Private Limited (since 2021). The company operates in Chemicals.

DIN 09176172
Primary Designation Director
Industry Chemicals
First Appointment 17 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dakshata Healthcare Private Limited U24299MH2021PTC360525
Director17 May 20212021Active

Board colleagues of Rasika Swapnesh Dhakare

NameDINCompanyDesignation
Swapnesh Sanjayrao Dhakre09176171Dakshata Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dakshata Healthcare Private Limited
Premium access

Shareholding and investment profile for Rasika Swapnesh Dhakare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rasika Swapnesh Dhakare

Rasika Swapnesh Dhakare currently holds 1 directorship: Dakshata Healthcare Private Limited (Director, since 17 May 2021).

Rasika Swapnesh Dhakare was first appointed on 17 May 2021 as Director at Dakshata Healthcare Private Limited.

The current boards of Rasika Swapnesh Dhakare's companies include Swapnesh Sanjayrao Dhakre (Dakshata Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available